Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Senate Bill 39 Allows Up to $100 Million in Business Incentive Credits for Transformational Mixed-Use Development in the State of Ohio

Client Alert

Ohio Governor Mike DeWine signed Senate Bill 39 on December 29, 2020, which created a new tax credit applicable to insurance premium taxes. This tax credit is designed to provide funding for a transformational mixed-use development or “TMUD” in the state of Ohio.

Effective as of March 31, 2021, Senate Bill 39 authorizes the Ohio Tax Credit Authority (“OTCA”), within the Ohio Development Services Agency (“ODSA”), to award up to $100 million of total business incentive credits in each of the fiscal years 2020-2023, which will then be applied against insurance premium taxes. Individual projects are capped at $40 million. Of the $100 million, there remains a reserved amount of $20 million of such credits each fiscal year for projects not located within a “Major City”, which is within ten miles of a municipality with more than 100,000 people.           

What Qualifies as a TMUD Project?

According to O.R.C. 122.09, the development project may be certified as a TMUD by meeting the following requirements:

  1. Must consist of new construction or redevelopment, rehabilitation, or expansion of an existing vacant structure, or a combination of the two; and
  2. Must have a “transformational economic impact” on the site and surrounding area. Transformational economic impact can be measured through the estimated increased tax collections resulting from the increased activity of the development, which must exceed 10% of the development costs within five (5) years of certification (as measured by a preliminary economic impact study, although not yet defined); and
  3. Must be mixed-use (integrating some combination of retail, office, residential, recreation, structured parking, or other similar uses); and
  4. Must include a structure or structures that meet certain height, square footage, or increased payroll requirements (urban projects must include at least one new or previously vacant building that is a) at least 15 stories high, or b) has a floor area of at least 350,000 square feet, or c) after completion will be the site of employment accounting for at least $4 million in annual payroll, or d) includes two or more connected buildings that collectively have a floor area exceeding 350,000 square feet); and
  5. Cannot be completed unless the applicant receives the credit; and
  6. Must have estimated development costs exceeding $50 million if the project is located within ten miles of a Major City.

Who Can Apply?

Those who may apply for these TMUDs include either a) property owners, or b) insurance companies that contribute capital which is then used in the planning or construction of this type of eligible development. Insurance companies may ultimately claim this credit, as it is a credit against an entity’s Ohio insurance premium taxes. A property owner who originally applies and receives the TMUD credit may either transfer it to an insurance company or sell or transfer the rights to that credit to others in order to raise project capital.

What’s Next?

The state is currently undertaking rulemaking for this new incentive and developing program guidelines. These guidelines, as defined by the Director of ODSA, are expected to be released within the next 30 days. All TMUD projects must be certified by the OTCA by June 30, 2023.

For additional questions on this tax credit, please contact BMD Member Jason Butterworth at jabutterworth@bmdllc.com or (330) 374-3216.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.